Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment. Its technology aims to selectively and durably modify cells of the hematopoietic system for patients.
6 investors
Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression. The company serves healthcare professionals and patients with chronic autoimmune conditions.
6 investors
Formus Labs develops software for orthopaedic surgery, applying AI and algorithmic modeling to support surgical planning for hip and knee procedures. The company serves orthopaedic surgeons and the medical and pharmaceutical sectors.
6 investors
Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis. Its lead asset, DMR-001, is an investigational monoclonal antibody targeting mutCALR, with a first regulatory submission planned for mid-2026.
6 investors
Gossamer Bio is a clinical-stage biopharmaceutical company developing seralutinib, an investigational drug candidate for treating pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
6 investors
Healionics develops STARgraft, a synthetic vascular graft built on its STAR biomaterial scaffold that resists occlusion and infection to create a reliable bloodstream access site for kidney dialysis patients. The device has received FDA Breakthrough Device designation and targets the treatment of kidney failure through dialysis.
6 investors
HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients. The company markets its technology to healthcare providers internationally.
6 investors
Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma. Its commercialized bio-interventional solutions are used by surgeons in glaucoma patient care.
6 investors
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies. The company is building on research from academic institutions including Dana Farber Cancer Institute and MIT.
6 investors
Infinitopes develops immunotherapy treatments for cancer, focusing on immune-oncology and antigen discovery solutions aimed at improving patient outcomes and affordability in cancer care.
6 investors
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply. The pre-clinical stage biotech company is supported by federal grants and investor funding.
6 investors
Kopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction. The company operates in the biotech and cancer treatment space.
6 investors
Kura Oncology is a company in the oncology/medtech sector that provides grant support for independent medical education programs designed to enhance healthcare professionals' ability to diagnose and treat patients in Kura Oncology's therapeutic areas of interest.
6 investors
LightForce develops generative braces using artificial intelligence and 3D printing technology to create individualized orthodontic appliances tailored to each patient. The company serves orthodontic practices by manufacturing custom metal and ceramic braces and operates the largest U.S. facility for 3D-printed functional medical devices.
6 investors
Luminate develops medical device technology to address chemotherapy side effects, particularly hair loss and peripheral neuropathy, for oncology patients and healthcare providers. The company is advancing clinical-stage devices while supporting cancer patients, clinicians, and health systems.
6 investors
Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches. Clinically tested in US trials, the therapy is prescribed by doctors and requires one hour of use per day, six days a week.
6 investors
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments. The company focuses on developing therapeutics in the cell and gene therapy space.
6 investors
Memo Therapeutics AG is a late-stage biotech company developing therapeutic antibodies for patients with viral infections and cancer. Its lead program, potravitug, is in Phase II development to treat BK polyomavirus infection in kidney transplant recipients, with additional oncology programs targeting antibodies derived from tumor-infiltrating B-cells.
6 investors
Metsera was a clinical-stage biotechnology company developing injectable and oral medicines for obesity and metabolic diseases, including next-generation GLP-1 and amylin-based therapies. Acquired by Pfizer in 2025.
6 investors
Mindset Health develops digital health programs using hypnotherapy and mind-body medicine to help patients manage gastrointestinal disorders and improve health outcomes. The platform is delivered via mobile app and partnerships with health plans and medical centers globally.
6 investors
Moons provides invisible, removable dental aligners for teeth straightening in Mexico. The company delivers personalized treatment plans with 3D smile visualization, orthodontist follow-up, and aligner sets at prices starting from 27,990 MXN.
6 investors
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments. The company is founded on research from Stanford University scientists and is led by experienced biopharmaceutical industry executives.
6 investors
NasaClip is an ER doctor-designed, patented, hands-free device that applies steady pressure to stop nosebleeds in children and adults. The reusable, FDA-registered product is sold as a consumer medical device for home, school, and sports use.
6 investors
NearWave develops a handheld medical device using frequency domain near infrared spectroscopy (fdNIRS) to non-invasively measure tissue oxygen saturation and hemoglobin concentrations for clinical and research applications. The device is positioned for use in clinical diagnostics, sports medicine, and cardiovascular health assessment.
6 investors